SecBot SecBot
Insider Cluster (4 insiders) ·Filed May 5, 2026

CYTK

CYTOKINETICS INC
MIXED
Impact 4/10
Horizondays Processed6mo ago
Insider cluster: 4 insiders, $4.5M total
Actionable Insight ◆ Mixed

Monitor for continued insider selling in coming weeks; while the cluster is small, insider activity at earnings time often signals near-term profit-taking. The positive launch data supports the stock, but further sales from executives could weigh on sentiment.

DirectionMixed
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$74.84
T+0 close · May 5, 2026 · via day close
Latest settled
+2.15%
T+60 · $76.45
Vs SPY
−1.10%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 6 $74.84entry
  2. T+1 · 6mo ago −0.73%α −0.43% · $74.29
  3. T+5 · 6mo ago +3.18%α +2.02% · $77.22
  4. T+20 · 6mo ago −3.41%α −6.58% · $72.29
  5. T+60 · 4mo ago +2.15%α −1.10% · $76.45
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Multiple CYTK insiders, including CFO and CCO, sold shares totaling $4.53M on the same day as Q1 2026 earnings release showing strong MYQORZO launch. The cluster is small relative to market cap (0.055%) but notable for involving key executives and timing with positive news.

Key Financial Metrics

Direction
selling
Total Value
$4.5M
Insiders
4

Key Facts

  • 4 insiders sold shares on May 5, 2026, including CFO Lee Sung ($1.84M) and CCO Andrew Callos ($875K)
  • Total open-market sales: $4.53M, representing 0.055% of $8.2B market cap
  • Sales occurred on same day as Q1 earnings: MYQORZO launch revenue $4.8M, ACACIA-HCM trial positive
  • Directors Henderson and Wierenga also sold shares alongside derivative exercises

Financial Impact

Insiders sold $4.53M in open-market transactions, ~0.055% of market cap

insider selling

Risk Factors

  • Further insider selling could dampen investor sentiment
  • Commercial execution of MYQORZO launch may face headwinds
  • Regulatory or safety issues with aficamten in nHCM

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CYTK-1778012475448

Track record

46 reports on CYTK

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $56.13 +4.41% settles Dec 15
  2. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $56.13 +0.00% settles Dec 14
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $56.13 −0.09% settles Dec 9
  4. Nov 9, 20267d ago 144 Neutral 2/10 Entry $56.18 Now $56.13 −0.09% settles Dec 9
  5. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $56.13 +1.80% settles Dec 8
  6. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $56.13 +1.80% settles Dec 8
  7. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  8. Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $56.13 +1.04% settles Dec 4
  9. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $63.60 Now $56.13 −11.75% settles Dec 3
  10. Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $56.13 −9.51% settles Dec 1
Showing 10 of 46

US Market Status

Market Closed · Opens Wed (12h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026